Hui-Qi Dai

552 total citations
5 papers, 435 citations indexed

About

Hui-Qi Dai is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hui-Qi Dai has authored 5 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hui-Qi Dai's work include Cancer, Lipids, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and Ferroptosis and cancer prognosis (2 papers). Hui-Qi Dai is often cited by papers focused on Cancer, Lipids, and Metabolism (2 papers), RNA modifications and cancer (2 papers) and Ferroptosis and cancer prognosis (2 papers). Hui-Qi Dai collaborates with scholars based in China, Singapore and Macao. Hui-Qi Dai's co-authors include Jing Zhou, Guo‐Dong Lu, Feng Ji, Xiaowei Huang, Yong Wu, Zhongjie Li, Huan Shi, Jigang Wang, Jing-Huan Deng and Zixuan Wang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Pharmacology and Experimental & Molecular Medicine.

In The Last Decade

Hui-Qi Dai

5 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hui-Qi Dai China	5	276	246	238	66	44	5	435
Mengting Li China	11	294 1.1×	270 1.1×	214 0.9×	96 1.5×	57 1.3×	35	559
Xixu Zhu China	13	192 0.7×	233 0.9×	92 0.4×	114 1.7×	34 0.8×	31	544
Jie Zeng China	10	244 0.9×	95 0.4×	167 0.7×	62 0.9×	66 1.5×	43	433
Justin Hartke United States	2	275 1.0×	103 0.4×	210 0.9×	68 1.0×	69 1.6×	3	484
Ya Tian China	7	234 0.8×	111 0.5×	82 0.3×	59 0.9×	90 2.0×	10	451
Jianzhuang Ren China	12	180 0.7×	88 0.4×	102 0.4×	82 1.2×	26 0.6×	26	401
Xiaoli Liao China	13	238 0.9×	74 0.3×	120 0.5×	110 1.7×	25 0.6×	29	426
Zhong Tian China	13	347 1.3×	71 0.3×	289 1.2×	87 1.3×	95 2.2×	30	613
Zhengtian Li China	10	220 0.8×	81 0.3×	112 0.5×	87 1.3×	69 1.6×	25	442
Lixin Yang China	11	216 0.8×	88 0.4×	167 0.7×	61 0.9×	18 0.4×	18	459

Countries citing papers authored by Hui-Qi Dai

Since Specialization

Citations

This map shows the geographic impact of Hui-Qi Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui-Qi Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui-Qi Dai more than expected).

Fields of papers citing papers by Hui-Qi Dai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui-Qi Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui-Qi Dai. The network helps show where Hui-Qi Dai may publish in the future.

Co-authorship network of co-authors of Hui-Qi Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Hui-Qi Dai. A scholar is included among the top collaborators of Hui-Qi Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui-Qi Dai. Hui-Qi Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Zhou, Jing, Feng Ji, Yong Wu, et al.. (2022). Simultaneous treatment with sorafenib and glucose restriction inhibits hepatocellular carcinoma in vitro and in vivo by impairing SIAH1-mediated mitophagy. Experimental & Molecular Medicine. 54(11). 2007–2021. 19 indexed citations

2.

Shi, Huan, Xinyu Li, Yao Chen, et al.. (2020). Quercetin Induces Apoptosis via Downregulation of Vascular Endothelial Growth Factor/Akt Signaling Pathway in Acute Myeloid Leukemia Cells. Frontiers in Pharmacology. 11. 534171–534171. 41 indexed citations

3.

Ji, Feng, Guangzhi Zhu, Shing Chuan Hooi, et al.. (2020). ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma. Acta Pharmacologica Sinica. 42(1). 160–170. 126 indexed citations

4.

Li, Zhongjie, Hui-Qi Dai, Xiaowei Huang, et al.. (2020). Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma. Acta Pharmacologica Sinica. 42(2). 301–310. 241 indexed citations

5.

Hu, Xiaoxiao, Feng Ji, Xiaowei Huang, et al.. (2019). Histone deacetylases up-regulate C/EBPα expression through reduction of miR-124-3p and miR-25 in hepatocellular carcinoma. Biochemical and Biophysical Research Communications. 514(3). 1009–1016. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact